ContractLicensing and Supply Agreement • June 29th, 2004 • Xenova Group PLC • Biological products, (no disgnostic substances) • England
* CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN *.
Page 1 sur 13 LICENSING AND SUPPLY AGREEMENTLicensing and Supply Agreement • November 13th, 2006 • Auriga Laboratories, Inc. • Services-business services, nec • New York
Agreement made this 13th day of September, 2006, between Laboratoires Carilène S.A.S a corporation existing under the laws of France, and having its principal place of business at 7, rue du Chant des Oiseaux, 78360 Montesson-France (hereinafter referred to as “Supplier”), and Auriga Laboratories, Inc., existing under the laws of the State of Delaware, U.S.A, having its principal place of business at 5555 Triangle Parkway, Suite 300 – Norcross, Georgia 30092, U.S.A. (hereinafter referred to as “Buyer”).
LICENSING AND SUPPLY AGREEMENTLicensing and Supply Agreement • November 28th, 2005 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances)
THIS LICENSING AND SUPPLY AGREEMENT (this “Agreement”), effective as of this 31st day of October, 2005 (the “Effective Date”), is by and among GTC Biotherapeutics, Inc., a corporation organized under the laws of the Commonwealth of Massachusetts with its principal offices at 175 Crossing Boulevard, Suite 410, Framingham, Massachusetts 01702 (“GTC”), and ATIII LLC, a limited liability company organized under the laws of the State of Delaware having its principal place of business at 175 Crossing Boulevard, Framingham, Massachusetts 01702 which is a wholly owned (100%) subsidiary of GTC, (“ATIII LLC”), and LEO Pharma A/S, a corporation organized under the laws of Denmark, with its principal offices at Industriparken 55, DK-2750 Ballerup, Denmark (“LEO”). LEO, ATIII LLC and GTC may be referred to herein individually as a “Party” or collectively as the “Parties.”
